Philadelphia-negative chronic myeloproliferative neoplasms

about

Epidemiology of MPN: what do we know?Management of side effects of BCR/ABL-negative chronic myeloproliferative neoplasm therapies. Focus on anagrelide.Effects of Mutational Combinations on Philadelphia-Negative Myeloproliferative Neoplasms.

P2860

Q38240406-BDED5197-98C2-49C0-8D4C-A9264C04A8EE Q38586505-E21B4C74-4E63-4961-BDCD-5EBE763049BA Q42144629-2A51BAAB-0264-499D-A362-F0369C0B3D50

P2860

Philadelphia-negative chronic myeloproliferative neoplasms

Item

http://www.wikidata.org/entity/Q36283143

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Philadelphia-negative chronic myeloproliferative neoplasms

@ast

Philadelphia-negative chronic myeloproliferative neoplasms

@en

type

Item

label

Philadelphia-negative chronic myeloproliferative neoplasms

@ast

Philadelphia-negative chronic myeloproliferative neoplasms

@en

prefLabel

Philadelphia-negative chronic myeloproliferative neoplasms

@ast

Philadelphia-negative chronic myeloproliferative neoplasms

@en

P1476

Philadelphia-negative chronic myeloproliferative neoplasms

@en

P2093

Ana Clara Kneese Nascimento

http://www.w3.org/2001/XMLSchema#string

Carlos Sergio Chiattone

http://www.w3.org/2001/XMLSchema#string

Carmino Antonio De Souza

http://www.w3.org/2001/XMLSchema#string

Jose Vassallo

http://www.w3.org/2001/XMLSchema#string

Katia Borgia Pagnano

http://www.w3.org/2001/XMLSchema#string

Maria de Lourdes Lopes Ferrari Chauffaille

http://www.w3.org/2001/XMLSchema#string

Rosane Isabel Bittencourt

http://www.w3.org/2001/XMLSchema#string

Sandra Guerra Xavier

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

The World Health Organization (WHO) classification of the myeloid neoplasms

Guideline for investigation and management of adults and children presenting with a thrombocytosis

A gain-of-function mutation of JAK2 in myeloproliferative disorders

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

Standardization of bone marrow features--does it work in hematopathology for histological discrimination of different disease patterns?

European consensus on grading bone marrow fibrosis and assessment of cellularity.

Chronic idiopathic myelofibrosis: clinicopathologic features, pathogenesis, and prognosis.

P304

140-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5581/1516-8484.20120034

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232226510

http://www.w3.org/2001/XMLSchema#string

P698

23049404

http://www.w3.org/2001/XMLSchema#string

P932

3459391

http://www.w3.org/2001/XMLSchema#string

Philadelphia-negative chronic myeloproliferative neoplasms

about

P2860

P2860

Philadelphia-negative chronic myeloproliferative neoplasms

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932